Skip To Main Content
Dengke Yin on Muck Rack

Dengke Yin

As seen in: Wiley Online Library, ACS Publications
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Dengke

Contact Dengke, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Correction to “Enhancing the Antitumor Effect of Doxorubicin with Photosensitive Metal–Organic Framework Nanoparticles against Breast Cancer”

|
By Qianqian Jiang, Mengmeng Zhang, Quanwei Sun, Dengke Yin
The purpose of this supplement is to rectify inaccuracies identified within the original manuscript, primarily focusing on image misplacement and figure caption errors. In Section 3.3 (The Cytotoxicity and Intracellular Localization of F68-DOX@CuTPyP) in the original manuscript, Figure 3D of the manuscript, errors were identified in the F68-DOX@CuTPyP group. Specifically, the magnification was incorrect for the DOX red fluorescence images showing cellular uptake at 1 and 2 h.
Open in Who Shared Issue with article?

Enhancing the Antitumor Effect of Doxorubicin with Photosensitive Metal-Organic Framework Nanoparticles against Breast Cancer

|
By Qianqian Jiang, Mengmeng Zhang, Dengke Yin, Quanwei Sun
| ACS Publications
Download Hi-Res ImageDownload to MS-PowerPointCite This:Mol.
Open in Who Shared Issue with article?

Multiboosting of Cancer Immunotherapy by a Core-Shell Delivery System

|
By Mengmeng Zhang, Li Xu, Dengke Yin, Fuping Shao
| American Chemical Society
The synergy of chemotherapy and antiangiogenesis therapy is a new strategy for cancer treatment. In this paper, a well-developed core–shell nanoparticle loaded with gambogic acid (GA), heparin (HP), and the immunoadjuvant cytosine-phosphate-guanine oligonucleotide (CpG ODN), called GHC NP, was constructed to treat hepatocellular carcinoma. GHC NPs with liver targeting activity can effectively inhibit tumor cell proliferation and angiogenesis.
Open in Who Shared Issue with article?
See all 4 articles